5AM Venture Management, LLC

SAN FRANCISCO, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$297.0M2026 Q3
Positions16
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.91.2%

5AM Venture Management, LLC reported 16 positions worth $297.0M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: LTGO (41.2%). Biggest move: new buy LTGO ($122.3M).

10 / 16 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 LTGOLatigo Biotherapeutics$122.3M41.19%7,325,962——-22.6%
▸ 2 TRDAEntrada Therapeutics$24.0M8.09%3,784,650——-19.8%
▸ 3 TYRATyra Biosciences$22.5M7.58%1,029,298——-8.5%
▸ 4 CAMPCamp4 Therapeutics$21.3M7.18%5,277,216——-5.9%
▸ 5 ARTVArtiva Biotherapeutics$16.8M5.64%2,353,304——-44.4%
▸ 6 PHVSPharvaris N.V.$15.2M5.13%479,900——+2.3%
▸ 7 TECXTectonic Therapeutic$14.1M4.76%606,660——-9.2%
▸ 8 CLDXCelldex Therapeutics$13.7M4.61%422,270———
▸ 9 ZNTLZentalis Pharmaceuticals$10.9M3.68%3,947,913——-38.6%
▸ 10 BHVNBiohaven$9.9M3.32%738,972———

Pro Feature

The remaining 6 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does 5AM Venture Management, LLC hold as of Q3 2026?

5AM Venture Management, LLC reported 16 positions worth $297.0M in its Q3 2026 13F filing. Largest positions: LTGO (41.2%), TRDA (8.1%), TYRA (7.6%), CAMP (7.2%) and ARTV (5.6%).

What did 5AM Venture Management, LLC buy in Q3 2026?

New positions: LTGO and SKYE BIOSCIENCE INC.

What did 5AM Venture Management, LLC sell in Q3 2026?

Reduced: PHVS, CLDX, CAMP, MPLT and TRDA. Sold out entirely: SRZN and SKYE BIOSCIENCE INC.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.